The results demonstrated that better tumor-killing effects was observed in the si-UGT1A10 group for gemcitabine, irinotecan, cisplatin, and paclitaxel, but worse drug sensitivity was detected for 5-FU. The gene discussed is UGT1A10; the disease is neoplasm.